Mutations in the GJB2 gene (encoding for Connexin 26 protein) represent a leading cause of genetic hearing impairment. Extensive epidemiological and molecular studies have been reported, describing GJB2 mutations type, frequency and distribution. Moreover, several aspects of GJB2 mutations pathogenic effects have been elucidated taking advantage of in vitro and in vivo experimental approaches. Progress through reported studies is reviewed, highlighting recent major achievements in this field. Attention is focused on different unresolved questions regarding GJB2 deafness pathogenesis and genotype-phenotype relationships. Clarification of these important clues will significantly increase our understanding of the molecular basis of hearing loss and will improve the effectiveness of diagnosis and counselling of this frequent disease.

Gorlin RJ, Toriello HV, Cohen MM: Hereditary hearing loss and its syndromes. Oxford, Oxford University Press, 1995.
Van Camp G, Willems PJ, Smith RJH: Nonsyndromic hearing impairment: Unparalleled heterogeneity. Am J Hum Genet 1997;60:758–764.
Kelsell DP, Dunlop J, Stevens HP, Lench NJ, Liang JN, Parry G, Mueller RF, Leigh IM: Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 1997;387:80–83.
Zelante L, Gasparini P, Estevill X, Melchionda S, D’Agruma L, Govea N, Mila M, Monica MD, Lutfi J, Shohat M, Mansfield E, Del Grosso K, Rappaport E, Surrey S, Fortina P: Connexin 26 mutations associated with the most common form of non-syndromic neurosensory autosomal deafness (DFNB1) in Mediterraneans. Hum Mol Genet 1997;6:1605–1609.
Bruzzone R, White WT, Paul DL: Connections with connexins: The molecular basis of direct intercellular signalling. Eur J Biochem 1996;238:1–27.
Estivill X, Fortina P, Surrey S, Rabionet R, Melchionda S, D’Agruma L, Mansfield E, Rappaport E, Govea N, Mila M, Zelante L, Gasparini P: Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet 1998;351:394–398.
Lench N, Houseman M, Newton W, Van Camp G, Mueller R: Connexin-26 mutations in sporadic nonsyndromal sensorineural deafness. Lancet 1998;351:415.
Denoyelle F, Weil D, Maw MA, Wilcox SA, Lench NJ, Allen-Powell DR, Osborn AH, Dahl HH, Middleton A, Houseman MJ, Dode C, Marlin S, Boulila-ElGaied A, Grati M, Ayadi H, BenArab S, Bitoun P, Lina-Granade G, Godet J, Mustapha M, Loiselet J, El-Zir E, Aubois A, Joannard A, Levilliers J, Garabedian EN, Mueller RF, McKinlay Gardner RJ, Petit C: Prelingual deafness: High prevalence of 30delG mutation in the connexin 26 gene. Hum Mol Genet 1997;6:2173–2177.
Kelley PM, Harris DJ, Comer BC, Askew JW, Fowler T, Smith SD, Kimberling WJ: Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss. Am J Hum Genet 1998;62:792–799.
Scott DA, Kraft ML, Carmi R, Ramesh A, Elbedour K, Yairi Y, Srisailapathy CR, Rosengren SS, Markham AF, Mueller RF, Lench NJ, Van Camp G, Smith RJ, Sheffield VC: Identification of mutations in the connexin 26 gene that cause autosomal recessive nonsyndromic hearing loss. Hum Mutat 1998a;11:387–394.
Gasparini P, Rabionet R, Barbujani G, Melchionda S, Petersen M, Brondum-Nielsen K, Metspalu A, Oitmaa E, Pisano M, Fortina P, Zelante L, Estivill X: High carrier frequency of the 35delG deafness mutation in European populations. Genetic Analysis Consortium of GJB2 35delG. Eur J Hum Genet 2000;8:19–23.
Van Laer L, Coucke P, Mueller RF, Caethoven G, Flothmann K, Prasad SD, Chamberlin GP, Houseman M, Taylor GR, Van de Heyning CM, Fransen E, Rowland J, Cucci RA, Smith RJH, Van Camp G: A common founder for the 35delG GJB2 gene mutation in connexin 26 hearing impairment. J Med Genet 2001;38:515–518.
Rothrock CR, Murgia A, Sartorato EL, Leonardi E, Wei S, Lebeis SL, Yu LE, Elfenbein JL, Fisher RA, Friderici KH: Connexin 26 35delG does not represent a mutational hotspot. Hum Genet 2003;113:18–23.
Lerer I, Sagi M, Malamud E, Levi H, Raas-Rothschild A, Abeliovich D: Contribution of connexin 26 mutations to non-syndromic deafness in Ashkenazi patients and the variable phenotypic effect of the mutation 167delT. Am J Med Genet 2000;95:53–56.
Liu XZ, Xia XJ, Ke XM, Ouyang XM, Du LL, Liu YH, Angeli S, Telischi FF, Nance WE, Balkany T, Xu LR: The prevalence of connexin 26 ( GJB2) mutations in the Chinese population. Hum Genet 2002;111:394–397.
Ohtsuka A, Yuge I, Kimura S, Namba A, Abe S, Van Laer L, Van Camp G, Usami S: GJB2 deafness gene shows a specific spectrum of mutations in Japan, including a frequent founder mutation. Hum Genet 2003;112:329–333.
Rickard S, Kelsell DP, Sirimana T, Rajput K, MacArdle B, Bitner-Glindzicz M: Recurrent mutations in the deafness gene GJB2 (connexin 26) in British Asian families. J Med Genet 2001;38:530–533.
Denoyelle F, Lina-Granade G, Plauchu H, Bruzzone R, Chaib H, Levi-Acobas F, Weil D, Petit C: Connexin 26 linked to dominant deafness. Nature 1998;393:319–320.
Heathcote K, Syrris P, Carter ND, Patton MA: A connexin 26 mutation causes a syndrome of sensorineural hearing loss and palmoplantar hyperkeratosis (MIM 148350). J Med Genet 2000;37:50–51.
Richard G, White TW, Smith LE, Bailey RA, Compton JG, Paul DL, Bale SJ: Functional defects of Cx26 resulting from a heterozygous missense mutation in a family with dominant deaf-mutism and palmoplantar keratoderma. Hum Genet 1998;103:393–399.
Maestrini E, Korge BP, Ocana-Sierra J, Calzolari E, Cambiaghi S, Scudder PM, Hovnanian A, Monaco AP, Munro CS: A missense mutation in connexin 26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel’s syndrome) in three unrelated families. Hum Mol Genet 1999;8:1237–1243.
Van Geel M, Van Steensel MAM, Kuster W, Hennies HC, Happle R, Steijlen PM, Konig A: HID and KID syndromes are associated with the same connexin 26 mutation. Br J Dermatol 2002;146:938–942.
Denoyelle F, Marlin S, Weil D, Moatti L, Chauvin P, Garabedian EN, Petit C: Clinical features of the prevalent form of childhood deafness, DFNB1, due to a connexin 26 gene defect: implication for genetic counselling. Lancet 1999;353:1298–1303.
Wilcox SA, Saunders K, Osborn AH, Arnold A, Wunderlich J, Kelly T, Collins V, Wilcox LJ, McKinlay Gardner RJ, Kamarinos M, Cone-Wesson B, Williamson R, Dahl HH: High frequency hearing loss correlated with mutations in the GJB2 gene. Hum Genet 2000;106:399–405.
Gualandi F, Ravani A, Berto A, Sensi A, Trabanelli C, Falciano F, Trevisi P, Mazzoli M, Tibiletti MG, Cristofari E, Burdo S, Ferlini A, Martini A, Calzolari E: Exploring the clinical and epidemiological complexity of GJB2-linked deafness. Am J Med Genet 2002;112:38–45.
Cohn ES, Kelley PM, Fowler TW, Gorga MP, Lefkowitz DM, Kuehn HJ, Schaefer GB, Gobar LS, Hahn FJ, Harris DJ, Kimberling WJ: Clinical studies of families with hearing loss attributable to mutations in the connexin 26 gene (GJB2/DFNB1). Pediatrics 1999;103:546–550.
Murgia A, Orzan E, Polli R, Martella M, Vinanzi C, Leopardi E, Arslan E, Zacchello F: Cx26 deafness: Mutation analysis and clinical variability. J Med Genet 1999;36:829–832.
Janecke AR, Hirst-Stadlmann A, Gunther B, Utermann B, Muller T, Loffler J, Utermann G, Nekahm-Heis D: Progressive hearing loss, and recurrent sudden sensorineural hearing loss associated with GJB2 mutations – phenotypic spectrum and frequencies of GJB2 mutations in Austria. Hum Genet 2002;111:145–153.
Loffler J, Nekahm D, Hirst-Stadlmann A, Gunther B, Menzel HJ, Utermann G, Janecke AR: Sensorineural hearing loss and the incidence of Cx26 mutations in Austria. Eur J Hum Genet 2001;9:226–230.
Green GE, Smith RJ, Bent JP, Cohn ES: Genetic testing to identify deaf newborns. JAMA 2000;284:1245.
Engel-Yeger B, Zaaroura S, Zlotogora J, Shalev S, Hujeirat Y, Carrasquillo M, Saleh B, Pratt H: Otoacoustic emissions and brainstem evoked potentials in compound carriers of connexin 26 mutations. Hear Res 2003;175:140–151.
Engel-Yeger B, Zaaroura S, Zlotogora J, Shalev S, Hujeirat Y, Carrasquillo M, Barges S, Pratt H: The effects of a connexin 26 mutation –35delG – on otoacoustic emissions and brainstem evoked potentials: Homozygotes and carriers. Hear Res 2002;163:93–100.
Scott DA, Kraft ML, Stone EM, Sheffield VC, Smith RJ: Connexin mutations and hearing loss. Nature 1998;391:32.
Houseman MJ, Ellis LA, Pagnamenta A, Di WL, Rickard S, Osborn AH, Dahl HH, Taylor GR, Bitner-Glindzicz M, Reardon W, Mueller RF, Kelsell DP: Genetic analysis of the connexin-26 M34T variant: Identification of genotype M34T/M34T segregating with mild-moderate non-syndromic sensorineural hearing loss. J Med Genet 2001;38:20–25.
Martin PE, Coleman SL, Casalotti SO, Forge A, Evans WH: Properties of connexin 26 gap junctional proteins derived from mutations associated with non-syndromal hereditary deafness. Hum Mol Genet 1999;8:2369–2376.
Rabionet R, Lopez-Bigas N, Arbones ML, Estivill X: Connexin mutations in hearing loss, dermatological and neurological disorders. Trends Mol Med 2002;8:205–212.
Choung YH, Moon SK, Park HJ: Functional study of GJB2 in hereditary hearing loss. Laryngoscope 2002;112:1667–1671.
D’Andrea P, Veronesi V, Bicego M, Melchionda S, Zelante L, Di Iorio E, Bruzzone R, Gasparini P: Hearing loss: frequency and functional studies of the most common connexin26 alleles. Biochem Biophys Res Commun 2002;296:685–691.
Thonnissen E, Rabionet R, Arbones ML, Estivill X, Willecke K, Ott T: Human connexin26 (GJB2) deafness mutations affect the function of gap junction channels at different levels of protein expression. Hum Genet 2002;11:190–197.
Wang HL, Chang WT, Li AH, Yeh TH, Wu CY, Chen MS, Huang PC: Functional analysis of connexin-26 mutants associated with hereditary recessive deafness. J Neurochem 2003;84:735–742.
White TW, Deans MR, Kelsell DP, Paul DL: Connexin mutations in deafness. Nature 1998;394:630–631.
Bruzzone R, Veronesi V, Gomes D, Bicego M, Duval N, Marlin S, Petit C, D’Andrea P, White TW: Loss-of-function and residual channel activity of connexin 26 mutations associated with non-syndromic deafness. FEBS Lett 2003;533:79–88.
Kudo T, Kure S, Ikeda K, Xia AP, Katori Y, Suzuki M, Kojima K, Ichinohe A, Suzuki Y, Aoki Y, Kobayashi T, Matsubara Y: Transgenic expression of a dominant-negative connexin 26 causes degeneration of the organ of Corti and non-syndromic deafness. Hum Mol Genet 2003;12:995–1004.
Cohen-Salmon M, Ott T, Michel V, Hardelin JP, Perfettini I, Eybalin M, Wu T, Marcus DC, Wangemann P, Willecke K, Petit C: Targeted ablation of connexin 26 in the inner ear epithelial gap junction network causes hearing impairment and cell death. Curr Biol 2002;12:1106–1111.
Kikuchi T, Kimura RS, Paul DL, Takasaka T, Adams JC: Gap junction system in the mammalian cochlea. Brain Res Rev 2000;32:163–166.
Lefebvre PP and Van de Water TR: Connexins, hearing and deafness: Clinical aspects of mutations in the connexin 26 gene. Br Res Rev 2000;32:159–162.
Liu XZ, Xia XJ, Ke XM, Ouyang XM, Du LL, Liu YH, Angeli S, Telischi FF, Nance WE, Balkany T, Xu LR: The prevalence of connexin 26 (GJB2) mutations in the Chinese population. Hum Genet 2002;111:394–397.
Xia A, Katori Y, Oshima T, Watanabe K, Kikuchi T, Ikeda K: Expression of connexin 30 in the developing mouse cochlea. Brain Res 2001;898:364–367.
Liu XZ, Xia XJ, Adams J, Chen ZY, Welch KO, Tekin M, Ouyang XM, Kristiansen A, Pandya A, Balkany T, Arnos KS, Nance WE: Mutations in GJA1 (connexin 43) are associated with non-syndromic autosomal recessive deafness. Hum Mol Genet 2001;10:2945–2951.
Lautermann J, Frank HG, Jahnke K, Traub O, Winterhager E: Developmental expression patterns of connexin 26 and 30 in the rat cochlea. Dev Genet 1999;25:306–311.
Kammen-Jolly K, Ichiki H, Scholtz AW, Gsenger M, Kreczy A, Schrott-Fischer A: Connexin 26 in human fetal development of the inner ear. Hear Res 2001;160:15–21.
Xia AP, Ikeda K, Katori Y, Oshima T, Kikuchi T, Takasaka T: Expression of connexin 31 in the developing mouse cochlea. Neuroreport 2000;11:2449–2453.
Lautermann J, Ten Cate WJ, Altenhoff P, Grummer R, Traub O, Frank H, Jahnke K, Winterhager E: Expression of the gap-junction connexins 26 and 30 in the rat cochlea. Cell Tissue Res 1998;294:415–420.
Marziano NK, Casalotti SO, Portelli AE, Becker DL, Forge A: Mutations in the gene for connexin 26 (GJB2) that cause hearing loss have a dominant negative effect on connexin 30. Hum Mol Genet 2003 Apr 15;12:805–812.
Lerer I, Sagi M, Ben-Neriah Z, Wang T, Levi H, Abeliovich D. A deletion mutation in GJB6 cooperating with a GJB2 mutation in trans in non-syndromic deafness: A novel founder mutation in Ashkenazi Jews. Hum Mutat 2001;18:460.
Del Castillo I, Villamar M, Moreno-Pelayo MA, Del Castillo FJ, Alvarez A, Telleria D, Menendez I, Moreno F: A deletion involving connexin 30 gene in nonsyndromic hearing impairment. N Engl J Med 2002 ; 346:243–249.
Pallares-Ruiz N, Blanchet P, Mondain M, Claustres M, Roux AF: A large deletion including most of GJB6 in recessive non syndromic deafness: a digenic effect? Eur J Hum Genet 2002;10:72–76.
Stevenson VA, Ito M, Milunsky JM: Connexin-30 deletion analysis in connexin-26 heterozygotes. Genet Test 2003;7:151–154.
Pandya A, Arnos KS, Xia XJ, Welch KO, Blanton SH, Friedman TB, Garcia Sanchez G, Liu MD XZ, Morell R, Nance WE: Frequency and distribution of GJB2 (connexin 26) and GJB6 (connexin 30) mutations in a large North American repository of deaf probands. Genet Med 2003;5:295–303.
Simon AM and Goodenough DA: Diverse function of vertebrate gap-junctions. Trends Cell Biol 1998;8:477–483.
Rouan F, White TW, Brown N, Taylor AM, Lucke TW, Paul DL, Munro CS, Uitto J, Hodgins MB, Richard G: Trans-dominant inhibition of connexin-43 by mutant connexin-26:implications for dominant connexin disorders affecting epidermal differentiation. J Cell Sci 2001;114:2105–2113.
Abe S, Kelley PM, Kimberling WJ, Usami SI: Connexin 26 gene (GJB2) mutation modulates the severity of hearing loss associated with the 1555A→G mitochondrial mutation. Am J Med Genet 2001;103:334–338.
Kubisch C, Schroeder BC, Friedrich T, Lutjohann B, El-Amraoui A, Marlin S, Petit C, Jentsch TJ: KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell 1999;96:437–446.
Boettger T, Hubner CA, Maier H, Rust MB, Beck FX, Jentsch TJ: Deafness and renal tubular acidosis in mice lacking the K-Cl co-transporter Kcc4. Nature 2002;416:874–878.
Michel V, Hardelin J-P, Petit C: Molecular mechanism of a frequent genetic form of deafness. N Engl J Med 2003;349:716–717.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.